United States of America (USA)

1 December 2019 - 30 November 2020

Subject/journal group: All

The table to the right includes counts of all research outputs for United States of America (USA) published between 1 December 2019 - 30 November 2020 which are tracked by the Nature Index.

Hover over the donut graph to view the FC output for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.

Note: Articles may be assigned to more than one subject area.

Count Share
28986 20575.61

Outputs by subject (FC)

Subject Count Share
Life Sciences 12951 9608.83
113 68.86
92 74.32
DNA Sensing in Mismatch Repair-Deficient Tumor Cells Is Essential for Anti-tumor Immunity.
2020-11-28
1
Molecular Features of Cancers Exhibiting Exceptional Responses to Treatment.
2020-11-16
0.93
A High-Resolution Map of Human Enhancer RNA Loci Characterizes Super-enhancer Activities in Cancer.
2020-11-09
1
COVID-19: Staging of a New Disease.
2020-11-09
1
Can Genomic Sequencing Identify High-Risk Barrett's Esophagus Earlier Than Pathologists?
2020-11-09
1
Combination Therapy for Solid Tumors: Taking a Classic CAR on New Adventures.
2020-11-09
1
Cytokine Storms in Cancer and COVID-19.
2020-11-09
0.87
Predicting Drug Response and Synergy Using a Deep Learning Model of Human Cancer Cells.
2020-11-09
1
SARS-CoV-2 Viral Load Predicts Mortality in Patients with and without Cancer Who Are Hospitalized with COVID-19.
2020-11-09
1
Supporting Clinical Decision-Making during the SARS-CoV-2 Pandemic through a Global Research Commitment: The TERAVOLT Experience.
2020-11-09
0.25
The HOLA COVID-19 Study: An International Effort to Determine How COVID-19 Has Impacted Oncology Practices in Latin America.
2020-11-09
0.57
Unraveling the Enigmatic Origin of Neuroblastoma.
2020-11-09
1
The Evolution of Angiogenic and Inflamed Tumors: The Renal Cancer Paradigm.
2020-11-05
1
Molecular Subsets in Renal Cancer Determine Outcome to Checkpoint and Angiogenesis Blockade.
2020-10-28
0.86
Large-Scale Characterization of Drug Responses of Clinically Relevant Proteins in Cancer Cell Lines.
2020-10-26
1
Senescence Reprogramming by TIMP1 Deficiency Promotes Prostate Cancer Metastasis.
2020-10-26
0.08
YTHDF3 Induces the Translation of m6A-Enriched Gene Transcripts to Promote Breast Cancer Brain Metastasis.
2020-10-16
0.94
Cholesterol Biosynthesis Influences Subtype Specificity and Plasticity in Pancreas Cancer.
2020-10-12
1
Cholesterol Pathway Inhibition Induces TGF-β Signaling to Promote Basal Differentiation in Pancreatic Cancer.
2020-10-12
0.99
Metabolic Imaging Detects Resistance to PI3Kα Inhibition Mediated by Persistent FOXM1 Expression in ER+ Breast Cancer.
2020-10-12
0.13
Next-Generation Analytics for Omics Data.
2020-09-23
1
Cancer Screening, Surrogates of Survival, and the Soma.
2020-09-16
0.25
Completing the Great Unfinished Symphony of Cancer Together: The Importance of Immigrants in Cancer Research
2020-09-14
1
Mastering the Complex Targeted Therapy for Non-small Cell Lung Cancer.
2020-09-14
1
Same Script, Different Cast: Different Cell Origins Shape Molecular Features and Therapeutic Response in Glioblastoma
2020-09-14
1
Text Messaging to Increase Compliance with Adjuvant Endocrine Therapy in Breast Cancer.
2020-09-14
1
Conserved Interferon-γ Signaling Drives Clinical Response to Immune Checkpoint Blockade Therapy in Melanoma.
2020-09-08
0.89
Lymph: (Fe)rrying Melanoma to Safety.
2020-09-02
0.50
Nivolumab Plus Ipilimumab for Metastatic Castration-Resistant Prostate Cancer: Preliminary Analysis of Patients in the CheckMate 650 Trial.
2020-08-31
0.67
FOXA1 Mutations Reveal Distinct Chromatin Profiles and Influence Therapeutic Response in Breast Cancer.
2020-08-25
0.80
Integrated Omics of Metastatic Colorectal Cancer.
2020-08-25
0.09
Hematopoietic Progenitor Kinase1 (HPK1) Mediates T Cell Dysfunction and Is a Druggable Target for T Cell-Based Immunotherapies.
2020-08-19
0.05
Emergence of a High-Plasticity Cell State during Lung Cancer Evolution.
2020-08-10
0.94
Epigenomic State Transitions Characterize Tumor Progression in Mouse Lung Adenocarcinoma.
2020-08-10
1
Microenvironment-Mediated Resistance to Anti-Androgen Therapy.
2020-08-10
1
Tumor Microenvironment-Derived NRG1 Promotes Antiandrogen Resistance in Prostate Cancer.
2020-08-10
1
Integrated Metabolic and Epigenomic Reprograming by H3K27M Mutations in Diffuse Intrinsic Pontine Gliomas.
2020-07-30
1
Single-Cell RNA-Seq Reveals Cellular Hierarchies and Impaired Developmental Trajectories in Pediatric Ependymoma.
2020-07-13
0.52
Cell Lineage-Based Stratification for Glioblastoma.
2020-06-23
1
Telomere Stress Potentiates STING-Dependent Anti-tumor Immunity.
2020-06-10
1
Clinically Actionable Strategies for Studying Neural Influences in Cancer.
2020-06-09
0.38
PKCλ/ι Loss Induces Autophagy, Oxidative Phosphorylation, and NRF2 to Promote Liver Cancer Progression
2020-06-09
0.97
CAR T Cells for Mantle Cell Lymphoma: Is it Time to Reshuffle the Deck?
2020-06-08
1
Cross-Presentation of Tumor Antigens Is Ruled by Synaptic Transfer of Vesicles among Dendritic Cell Subsets.
2020-06-08
1
Multi-phenotype CRISPR-Cas9 Screen Identifies p38 Kinase as a Target for Adoptive Immunotherapies.
2020-06-08
1
Visualizing Synaptic Transfer of Tumor Antigens among Dendritic Cells
2020-06-08
1
Altered RNA Splicing by Mutant p53 Activates Oncogenic RAS Signaling in Pancreatic Cancer.
2020-06-02
0.84
Targeting RSPO3-LGR4 Signaling for Leukemia Stem Cell Eradication in Acute Myeloid Leukemia
2020-06-01
0.14
MYC Drives Temporal Evolution of Small Cell Lung Cancer Subtypes by Reprogramming Neuroendocrine Fate.
2020-05-30
1
Unbiased Proteomic Profiling Uncovers a Targetable GNAS/PKA/PP2A Axis in Small Cell Lung Cancer Stem Cells.
2020-05-22
1
Extensive Remodeling of the Immune Microenvironment in B Cell Acute Lymphoblastic Leukemia.
2020-05-14
1
MAX Functions as a Tumor Suppressor and Rewires Metabolism in Small Cell Lung Cancer.
2020-05-13
0.96
SETD5-Coordinated Chromatin Reprogramming Regulates Adaptive Resistance to Targeted Pancreatic Cancer Therapy.
2020-05-13
1
Targeting FTO Suppresses Cancer Stem Cell Maintenance and Immune Evasion
2020-05-13
0.88
Comprehensive Analysis of Genetic Ancestry and Its Molecular Correlates in Cancer.
2020-05-11
0.90
Comprehensive Molecular Characterization Identifies Distinct Genomic and Immune Hallmarks of Renal Medullary Carcinoma.
2020-05-11
0.93
Mutant EZH2 Induces a Pre-malignant Lymphoma Niche by Reprogramming the Immune Response.
2020-05-11
0.85
The COVID-19 and Cancer Consortium: A Collaborative Effort to Understand the Effects of COVID-19 on Patients with Cancer.
2020-04-29
0.83
A Probabilistic Classification Tool for Genetic Subtypes of Diffuse Large B Cell Lymphoma with Therapeutic Implications.
2020-04-13
0.78
Integrated Molecular and Clinical Analysis of 1,000 Pediatric Low-Grade Gliomas.
2020-04-13
0.27
KMT2D Deficiency Impairs Super-Enhancers to Confer a Glycolytic Vulnerability in Lung Cancer.
2020-03-23
1
A Deregulated HOX Gene Axis Confers an Epigenetic Vulnerability in KRAS-Mutant Lung Cancers.
2020-03-19
1
ADORA1 Inhibition Promotes Tumor Immune Evasion by Regulating the ATF3-PD-L1 Axis.
2020-03-16
0.09
Breaking Down the Barriers to Define and Treat NK/T Cell Lymphoma.
2020-03-16
1
Chemotherapy and CDK4/6 Inhibition in Cancer Treatment: Timing Is Everything.
2020-03-16
1
Context-Dependent Immune Responses Explain Pancreatic Cancer Immunoresistance.
2020-03-16
1
Cyto-Immuno-Therapy for Cancer: A Pathway Elicited by Tumor-Targeted, Cytotoxic Drug-Packaged Bacterially Derived Nanocells.
2020-03-16
0.08
Dendritic Cell Paucity Leads to Dysfunctional Immune Surveillance in Pancreatic Cancer.
2020-03-16
1
It's All About MEis: Menin-MLL Inhibition Eradicates NPM1-Mutated and MLL-Rearranged Acute Leukemias in Mice.
2020-03-16
0.67
Loss of CHD1 Promotes Heterogeneous Mechanisms of Resistance to AR-Targeted Therapy via Chromatin Dysregulation.
2020-03-13
1
Neurofibromin Is an Estrogen Receptor-α Transcriptional Co-repressor in Breast Cancer.
2020-02-25
0.93
Mutant ACVR1 Arrests Glial Cell Differentiation to Drive Tumorigenesis in Pediatric Gliomas.
2020-02-21
0.09
Proteome Instability Is a Therapeutic Vulnerability in Mismatch Repair-Deficient Cancer.
2020-02-14
1
Circles with a Point: New Insights into Oncogenic Extrachromosomal DNA.
2020-02-10
1
Comparative Molecular Life History of Spontaneous Canine and Human Gliomas.
2020-02-10
0.97
Direct Phosphorylation and Stabilization of MYC by Aurora B Kinase Promote T-cell Leukemogenesis.
2020-02-10
0.11
Dynamic ROS Regulation by TIGAR: Balancing Anti-cancer and Pro-metastasis Effects.
2020-02-10
0.50
Opening a Door to PARP Inhibitor-Induced Lethality in HR-Proficient Human Tumor Cells.
2020-02-10
1
Unraveling the Signaling Balance of Activation and Exhaustion of CAR T Cells.
2020-02-10
1
CDK4/6 Inhibitors Impair Recovery from Cytotoxic Chemotherapy in Pancreatic Adenocarcinoma.
2020-02-07
0.29
EZH2 Inhibition Sensitizes CARM1-High, Homologous Recombination Proficient Ovarian Cancers to PARP Inhibition.
2020-01-22
1
Hyperactivation of TORC1 Drives Resistance to the Pan-HER Tyrosine Kinase Inhibitor Neratinib in HER2-Mutant Cancers.
2020-01-22
1
THEMIS-SHP1 Recruitment by 4-1BB Tunes LCK-Mediated Priming of Chimeric Antigen Receptor-Redirected T Cells.
2020-01-22
1
Dynamic ROS Control by TIGAR Regulates the Initiation and Progression of Pancreatic Cancer.
2020-01-13
0.29
Epigenetic Silencing of CDR1as Drives IGF2BP3-Mediated Melanoma Invasion and Metastasis.
2020-01-13
0.75
This Is Our Cells Under Pressure: Decreased DNA Damage Repair in Response to Targeted Therapies Facilitates the Emergence of Drug-Resistant Clones.
2020-01-13
1
Treatment-Induced Tumor Dormancy through YAP-Mediated Transcriptional Reprogramming of the Apoptotic Pathway.
2020-01-13
0.98
Vitamin B6 Addiction in Acute Myeloid Leukemia.
2020-01-13
1
A Menin-MLL Inhibitor Induces Specific Chromatin Changes and Eradicates Disease in Models of MLL-Rearranged Leukemia.
2019-12-09
0.57
CDK7 Inhibition Potentiates Genome Instability Triggering Anti-tumor Immunity in Small Cell Lung Cancer.
2019-12-09
0.96
The Tumor Microbiome in Pancreatic Cancer: Bacteria and Beyond.
2019-12-09
1
When Cold Is Hot: Immune Checkpoint Inhibition Therapy for Rhabdoid Tumors.
2019-12-09
1
263 209.84
286 222.26
98 73.98
93 64.78
102 81.37
1 1
290 206.53
119 97.31
70 44.50
1 0.44
72 61.25
98 69.18
88 68.97
789 660.54
139 109.68
370 282.30
123 83.23
416 350.22
180 140.73
162 112.95
477 328.90
99 78.77
72 51.49
109 84.90
2186 1421.72
92 55.28
1 0.83
78 51.61
153 105.50
74 60.03
108 85.85
81 64.61
213 182.14
156 106.03
284 216.28
1922 1480.98
265 182.56
328 233.82
699 499.53
217 169.33
99 47.48
118 85.79
71 40.81
1084 890.33
Earth & Environmental Sciences 4341 2853.57
Chemistry 7235 5250.77
Physical Sciences 8259 5364.59

1 December 2019 - 30 November 2020

View the connected world of international research collaboration. Visualize collaborations by subject or region.

Collaborations between countries

Percentage of collaboration by Share

Hover over the graph to view the percentage of collaboration.

Top 10 collaborators by Share

  • United States of America (USA)
  1. China (4420.77)
    2106.75
    2314.03
  2. 1144.34
    831.17
  3. Germany (1914.97)
    1082.34
    832.63
  4. Canada (1205.80)
    753.10
    452.71
  5. France (1078.91)
    656.65
    422.26
  6. Japan (974.94)
    598.68
    376.26
  7. Australia (712.66)
    427.56
    285.10
  8. Switzerland (698.47)
    414.10
    284.37
  9. South Korea (697.43)
    420.77
    276.66
  10. Italy (582.81)
    354.79
    228.01

Collaboration is determined by the combined fractional count (Share) of United States of America (USA) and the collaborating country.

Top 10 institutions from United States of America (USA)

Institution Count Share
1. Harvard University 2535 914
2. Stanford University 1694 647.18
3. Massachusetts Institute of Technology (MIT) 1828 528.46
4. National Institutes of Health (NIH) 1085 404.29
5. University of California, Berkeley (UC Berkeley) 1297 395.84
6. University of Michigan (U-M) 1010 391.33
7. Yale University 987 350.79
8. University of California, San Diego (UC San Diego) 1003 342.66
9. Columbia University in the City of New York (CU) 1027 327.89
10. University of California, Los Angeles (UCLA) 1114 327.29

Enhanced profiles

Get your institution here

Return to country/territory outputs